OpenFilings

EyePoint Pharmaceuticals, Inc.

Form8-K

Report Period2025-06-18

Date Filed2025-06-20

Time Filed07:05:27

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

8-K
EX-10.1
Filing on SEC Edgar